428 related articles for article (PubMed ID: 28322746)
21. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
[TBL] [Abstract][Full Text] [Related]
22. CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.
Mortier A; Gouwy M; Van Damme J; Proost P; Struyf S
J Leukoc Biol; 2016 Jun; 99(6):955-69. PubMed ID: 26744452
[TBL] [Abstract][Full Text] [Related]
23. CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Chen Q; Zhang M; Li Y; Xu D; Wang Y; Song A; Zhu B; Huang Y; Zheng JC
Stem Cells; 2015 Aug; 33(8):2574-85. PubMed ID: 25833331
[TBL] [Abstract][Full Text] [Related]
24. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
25. Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration.
Tobia C; Chiodelli P; Barbieri A; Buraschi S; Ferrari E; Mitola S; Borsani G; Guerra J; Presta M
Front Immunol; 2019; 10():1092. PubMed ID: 31156639
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
[TBL] [Abstract][Full Text] [Related]
27. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
28. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.
Levoye A; Balabanian K; Baleux F; Bachelerie F; Lagane B
Blood; 2009 Jun; 113(24):6085-93. PubMed ID: 19380869
[TBL] [Abstract][Full Text] [Related]
29. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
30. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J
Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140
[TBL] [Abstract][Full Text] [Related]
31. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
[TBL] [Abstract][Full Text] [Related]
32. CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons.
Abe P; Mueller W; Schütz D; MacKay F; Thelen M; Zhang P; Stumm R
Development; 2014 May; 141(9):1857-63. PubMed ID: 24718993
[TBL] [Abstract][Full Text] [Related]
33. CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.
Sun YX; Pedersen EA; Shiozawa Y; Havens AM; Jung Y; Wang J; Pienta KJ; Taichman RS
Clin Exp Metastasis; 2008; 25(7):765-76. PubMed ID: 18563594
[TBL] [Abstract][Full Text] [Related]
34. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
Hara T; Tanegashima K
Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
[TBL] [Abstract][Full Text] [Related]
35. CD26 inhibition enhances perfusion recovery in ApoE-/-mice.
Haverslag RT; de Groot D; Grundmann S; Meder B; Goumans MJ; Pasterkamp G; Hoefer IE; de Kleijn DP
Curr Vasc Pharmacol; 2013 Jan; 11(1):21-8. PubMed ID: 23391419
[TBL] [Abstract][Full Text] [Related]
36. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
[TBL] [Abstract][Full Text] [Related]
37. CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation.
Giegold O; Ogrissek N; Richter C; Schröder M; Herrero San Juan M; Pfeilschifter JM; Radeke HH
J Immunol; 2013 Apr; 190(7):3696-705. PubMed ID: 23447686
[TBL] [Abstract][Full Text] [Related]
38. SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26.
Hildebrandt M; Schabath R
Front Biosci; 2008 Jan; 13():1774-9. PubMed ID: 17981666
[TBL] [Abstract][Full Text] [Related]
39. Pathological roles of the homeostatic chemokine CXCL12.
Janssens R; Struyf S; Proost P
Cytokine Growth Factor Rev; 2018 Dec; 44():51-68. PubMed ID: 30396776
[TBL] [Abstract][Full Text] [Related]
40. The unique structural and functional features of CXCL12.
Janssens R; Struyf S; Proost P
Cell Mol Immunol; 2018 Apr; 15(4):299-311. PubMed ID: 29082918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
